How to achieve safe, high-quality clinical studies with non-Medicinal Investigational Products? A practical guideline by using intra-bronchial carbon nanoparticles as case study

BACKGROUND: Clinical studies investigating medicinal products need to comply with laws concerning good clinical practice (GCP) and good manufacturing practice (GMP) to guarantee the quality and safety of the product, to protect the health of the participating individual and to assure proper performa...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, M., Kooyman, P. J., Makkee, M., van der Zee, J. S., Sterk, P. J., van Dijk, J., Kemper, E. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992213/
https://www.ncbi.nlm.nih.gov/pubmed/27542842
http://dx.doi.org/10.1186/s12931-016-0413-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992213/
https://www.ncbi.nlm.nih.gov/pubmed/27542842
http://dx.doi.org/10.1186/s12931-016-0413-9

Ejemplares similares